Can lorazepam be distinguished from other short-acting benzodiazepines in regard to brain damage and withdrawal symptoms?
van Hiele, L.J.
Nederlands Tijdschrift Voor Geneeskunde 125(4): 156
1981
ISSN/ISBN: 0028-2162 PMID: 6111030 Document Number: 176564
Document emailed within 1 workday
Related Documents
Ayadi, N.; Neifar, S.; Maalej, M. 1998: Amnesic and criminal effect of benzodiazepines: case report with lorazepam Therapie 53(6): 596-598Rett, A. 1971: Clinical and psychological axis symptoms of brain damage in children Wiener Medizinische Wochenschrift 121(24): 498-500
Gupta, M.B.; Nath, C.; Patnaik, G.K.; Saxena, R.C. 1996: Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats Indian Journal of Medical Research 103: 310-314
Lemoine, P.; Rouillon, F.; Pouget, D. 1996: Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders L'Encephale 22(6): 461-467
Mouland, G. 2001: Practical advice on withdrawal of benzodiazepines Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(20): 2394-2395
Miller, W.C.; McCurdy, L. 1984: A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome Clinical Therapeutics 6(3): 364-371
Fossati, C. 1987: Untoward side effects of benzodiazepines: dependence and withdrawal syndrome La Clinica Terapeutica 122(5): 367-372
Vadiei, N.; Smith, T.L.; Walton, A.E.; Kjome, K.L. 2019: Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital Psychopharmacology Bulletin 49(1): 17-27
Das, M.; Anand, A.; Hossain, B.; Ansari, S. 2022: Inequalities in short-acting reversible, long-acting reversible and permanent contraception use among currently married women in India Bmc Public Health 22(1): 1264
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Van Steenkiste, M.; de Roeck, J. 1986: Dependence and abstinence symptoms in the use of benzodiazepines Nederlands Tijdschrift Voor Geneeskunde 130(27): 1224-1227
Christensen, H.R.; Simonsen, K. 1986: Benzodiazepines as hypnotics. the importance of short half-life Ugeskrift for Laeger 148(28): 1772-1774
Rao, Y.V.; Reddy, K.S.; Wasir, H.S. 1991: Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate Indian Heart Journal 43(2): 97-100
1988: Benzodiazepines during pregnancy: low doses for a short time do not increase risk Lakartidningen 85(36): 2875
Schylla, A.; Scisło, P.; Badura-Brzoza, K.; Pasierb, N. 2012: Description of a patient with schizophrenia and coexisting megadose lorazepam dependence with slightly expressed withdrawl symptoms during drug reduction. A case report Wiadomosci Lekarskie 65(4): 243-246
Borzeix, M.G.; Labos, M.; Cahn, J. 1972: Experimental model of brain edema for the study of drugs acting on blood flow and-or brain metabolism Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 13(4): 257-260
Berlin, C.S. 1996: Fluoxetine withdrawal symptoms Journal of Clinical Psychiatry 57(2): 93-94
Fagerström, K.O. 1999: Tobacco withdrawal symptoms and treatment Monaldi Archives for Chest Disease 54(6): 485-488
Stern, S.L.; Mendels, J. 1980: Withdrawal symptoms during the course of imipramine therapy Journal of Clinical Psychiatry 41(2): 66-67
Niemelä, S. 2011: Treatment of alcohol withdrawal symptoms Duodecim; Laaketieteellinen Aikakauskirja 127(13): 1373-1377